Senior Research Associate, Research Biology

Company Description

Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the intersection of chemistry, engineering, computation, and biology to discover novel treatments for life-threatening diseases. Eikon's discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes which enable real time, molecular-resolution measurements of protein movement in living cells, thereby unlocking otherwise intractable classes of proteins as drug targets.

Position

As a Research Associate at Eikon, you will join an interdisciplinary team of highly creative and talented individuals. You will collaborate with scientists to establish and validate in vitro cell-based functional assays that will be critical in aiding our Single Particle Tracking (SPT) drug discovery platform and compound Structure-Activity Relationship (SAR) campaigns. Your work will contribute to the coordinated small molecule discovery efforts of multidisciplinary project teams consisting of biologists, chemists, computer scientists, and microscope engineers
About you:

• You're a rigorous experimentalist who takes pride in your ability to execute at the bench.
• You're passionate about drug discovery and discovering effective treatments for patients.
• You're conscientious, detail oriented, and organized.
• You're collaborative by nature and are happy to help.
• You thrive in a fast-paced environment and enjoy pushing the edge of what is possible.

What you'll do:

• Plan and execute cellular/molecular biology and biochemical studies to support drug discovery programs including validating drug targets, developing disease-relevant assays, and elucidating the mechanisms of action of compounds.
• Keep detailed and organized records of experimental protocols and results.
• Analyze, interpret, and present scientific findings.
• Collaborate and communicate across a diverse research team to successfully progress scientific goals.

Required Qualifications:

• M.Sc. degree in cell biology, molecular biology, biochemistry, genetics, neuroscience, or a related field, with at least 3 years of additional research experience, preferably in industry; or B.Sc. with at least 6 years of industry experience
• Experience in discovering, validating, and/or characterizing drug targets through genetic and/or pharmacological approaches.
• Proficiency in standard cell and molecular biology techniques such as mammalian cell culture, molecular cloning, PCR/RT-PCR, Western blots, and transfection and transduction technologies
• Experience across multiple therapeutic areas
• Keen analytical and problem-solving skills.
• The ability to communicate clearly and build open collaborative relationships.

Desirable qualifications:

• Experience in Neurosciences
• Experience in fixed or live-cell fluorescent imaging, flow cytometry, CRISPR, Sanger and NGS sequencing, functional genomics or other omics-based approaches
• Experience with biochemical techniques such as protein expression and purification, enzymatic assays, binding assays, etc.

Eikon is proud to be an equal opportunity employer and will consider all qualified applicants for employment.

In accordance with the Company's duty to provide and maintain a safe workplace, the Company requires all employees to be Fully Vaccinated with one of the FDA approved COVID-19 vaccines, which includes those vaccines that have received the FDA's emergency use authorization. You will be expected to be Fully Vaccinated as of your Start Date. If you believe that you are exempt from this requirement under an applicable law or regulations, including Americans with Disabilities Act and California's Fair Employment and Housing Act, you will need to contact the Company's Human Resources group. For purposes of this section, Fully Vaccinated means (i) the completion of the vaccination regimen as approved by the FDA (by way of example, 2 doses of the Pfizer or Moderna vaccine and 1 dose of the Johnson and Johnson vaccine), and (ii) timely receiving booster vaccination, as recommended by the Centers for Disease Control and Prevention.